Separation Systems for Commercial Biotechnology Market USD 14.7 Billion by 2020 - iHealthcareAnalyst, Inc.

Maryland Heights, MO, October 23, 2016 --(PR.com)-- According to a market research report Separation Systems for Commercial Biotechnology Market 2013-2020, published by iHealthcareAnalyst, Inc., the global separation systems for commercial biotechnology market is estimated to reach USD 14.7 Billion in 2020, expanding at a CAGR of 5.4% from 2016 to 2020.

Visit the Separation Systems for Commercial Biotechnology Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/separation-systems-commercial-biotechnology-market/

The global separation systems for commercial biotechnology market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

The global separation systems for commercial biotechnology market segmentation is based on product types (centrifugation, DNA microarray, electrophoresis, flow cytometry, liquid chromatography, MCAS, FACS, membrane filtration, protein microarray), and end users (pharmaceuticals, research and diagnostics).

The global separation systems for commercial biotechnology market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global separation systems for commercial biotechnology market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Product Type
1.1. Centrifugation
1.2. DNA Microarray
1.3. Electrophoresis
1.4. Flow Cytometry
1.5. Liquid Chromatography
1.6. MACS and FACS Systems
1.7. Membrane Filtration
1.8. Protein Microarray
1.9. Others

2. End User
2.1. Pharmaceuticals
2.2. Research and Diagnostics

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Affymetrix, Inc.
4.2. Danaher Corporation
4.3. Becton, Dickinson and Company
4.4. Bio-Rad Laboratories, Inc.
4.5. GE Healthcare
4.6. Merck KGaA
4.7. PerkinElmer, Inc.
4.8. Qiagen
4.9. Thermo Fisher Scientific, Inc.
4.10. Waters Corporation

About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com